Sex (male, n)
|
Age (y) (mean ± SD)
|
57.74 ± 16.63
|
61.57 ± 13.69
|
0.448
| | |
APACHE II score at admission
|
11.50 ± 5.53
|
10.07 ± 4.95
|
0.406
| | |
APACHE II score on the day of bacteremia
|
18.29 ± 7.36
|
14.48 ± 6.11
|
0.031
| | |
Liver failurea at admission
|
7
|
8
|
0.784
|
1.188
|
0.348—4.051
|
Kidney failureb at Admission
|
4
|
7
|
0.574
|
0.672
|
0.168—2.694
|
Liver failure on the day of bacteremia
|
11
|
7
|
0.06
|
3.143
|
0.933—10.584
|
Kidney failure on the day of bacteremia
|
6
|
6
|
0.614
|
1.400
|
0.377—5.195
|
Co-infection
|
14
|
20
|
0.575
|
0.700
|
0.2—2.445
|
CRKp
|
12(57.1%)
|
19(70.3%)
|
0.342
|
0.561
|
0.170—1.856
|
Diabetes mellitus
|
5(23.8%)
|
9(23.3%)
|
0.371
|
0.556
|
0.152—2.027
|
Hypertension
|
10(47.6%)
|
14(51.9%)
|
0.771
|
0.844
|
0.270—2.644
|
Coronary heart disease
|
2(9.5%)
|
2(7.4%)
|
0.792
|
1.316
|
0.170—10.208
|
Chronic renal failure
|
2(9.5%)
|
4(14.8%)
|
0.582
|
0.605
|
0.1—3.672
|
Solid organ tumor
|
4(19%)
|
7(25.9%)
|
0.574
|
0.672
|
0.168—2.694
|
Surgery in the past medical history
|
2(9.5%)
|
6(22.2%)
|
0.242
|
0.368
|
0.066—2.050
|
Prior healthcare-associated exposure
|
8(38.1%)
|
8(29.6%)
|
0.537
|
1.462
|
0.437—4.889
|
Glucocorticoid
|
8
|
12
|
0.658
|
0.769
|
0.240—2.460
|
Immunosuppressor
|
2(9.5%)
|
1(3.7%)
|
0.409
|
2.737
|
0.231—32.430
|
Central venous catheterization
|
17(81%)
|
23(85.2%)
|
0.696
|
0.739
|
0.161—3.383
|
Trachea cannula
|
9(42.9%)
|
5(18.5%)
|
0.066
|
3.3
|
0.899—12.108
|
Tracheotomy
|
6(27.3%)
|
11(40.7%)
|
0.325
|
0.545
|
0.162—1.833
|
Urinary catheter
|
13(61.9%)
|
17(16.9%)
|
0.940
|
0.956
|
0.295—3.102
|
Abdominal cavity drainage- tube
|
6(28.6%)
|
14(51.9%)
|
0.105
|
0.371
|
0.111—1.247
|
Stomach tube
|
18(85.7%)
|
23(85.2%)
|
0.959
|
1.043
|
0.305—0.593
|
Intrathoracic drain
|
0
|
4(14.8%)
|
0.121
|
0.523
|
0.394—0.693
|
External ventricular drainage tube care
|
1(4.7%)
|
0
|
0.438
|
0.426
|
0.305—0.593
|